|
Guidelines
Citations 1-10 of 101 total displayed.
|
Most recent content
(15 Jun 2010):
|
- Review
Opioids for chronic noncancer pain: a new Canadian practice guideline
- Andrea D. Furlan, Rhoda Reardon, Clarence Weppler for the National Opioid Use Guideline Group (NOUGG)
Can. Med. Assoc. J. 2010; 182: 923-930.
[Full text]
[PDF]
[ Online Appendices ]
|
Past content
(since Jul 1999):
|
- Practice
Toward a more effective approach to stroke: Canadian Best Practice Recommendations for Stroke Care
- Patrice Lindsay, RN PhD, Mark Bayley, MD, Alison McDonald, BScPT, Ian D. Graham, PhD, Grace Warner, PhD, and Stephen Phillips, MBBS
Can. Med. Assoc. J. 2008; 178: 1418-1425.
[Abstract]
[Full text]
[PDF]
[ Résumé ] [ Online Appendices ]
- Commentary
A guide to the Canadian Medical Association Handbook on Clinical Practice Guidelines
- Valerie A. Palda, MD MSc, Dave Davis, MD, and Joanne Goldman, MSc
Can. Med. Assoc. J. 2007; 177: 1221-1226.
[Full text]
[PDF]
- Research
Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome
- Claudia Gagnon and Jean-Patrice Baillargeon
Can. Med. Assoc. J. 2007; 176: 933-938.
[Abstract]
[Full text]
[PDF]
- Commentary
Screening for diabetes in women with polycystic ovary syndrome
- David C.W. Lau
Can. Med. Assoc. J. 2007; 176: 951-952.
[Full text]
[PDF]
- Research
Canadian breast cancer guidelines: Have they made a difference?
- Steven Latosinsky, Katherine Fradette, Lisa Lix, Karen Hildebrand, and Donna Turner
Can. Med. Assoc. J. 2007; 176: 771-776.
[Abstract]
[Full text]
[PDF]
- Commentary
Canadian breast cancer guidelines are as effective as possible under the circumstances
- Eva Grunfeld
Can. Med. Assoc. J. 2007; 176: 785-786.
[Full text]
[PDF]
- Commentary
The Canadian Diabetes Association guidelines: putting the evidence first
- Michael C. Howlett and Donna Lillie
Can. Med. Assoc. J. 2006; 174: 333-a-334-a.
[Full text]
[PDF]
- Commentary
Guideline controversy
- John Hoey
Can. Med. Assoc. J. 2006; 174: 333.
[Full text]
[PDF]
- Commentary
On bias and transparency in the development of influential recommendations
- Andreas Laupacis
Can. Med. Assoc. J. 2006; 174: 335-336.
[Full text]
[PDF]
|
|
